Polyinosinic:polycytidylic acid
Synthetic analog of double-stranded RNA
Polyinosinic:polycytidylic acid (commonly abbreviated as poly I:C) is a synthetic analog of double-stranded RNA (dsRNA). It is composed of a strand of polyinosinic acid and a strand of polycytidylic acid, which form a double-stranded structure similar to that of viral RNA. Poly I:C is widely used in research to mimic viral infections and to study the immune response, particularly the activation of the innate immune system.
Structure and Composition[edit | edit source]
Poly I:C is a synthetic polynucleotide, consisting of two complementary strands: one made of inosine residues and the other of cytidine residues. These strands are hydrogen-bonded to form a stable double helix. The structure of poly I:C resembles that of viral dsRNA, which is recognized by the immune system as a pathogen-associated molecular pattern (PAMP).
Mechanism of Action[edit | edit source]
Poly I:C is recognized by several pattern recognition receptors (PRRs) in the immune system, including Toll-like receptor 3 (TLR3) and RIG-I-like receptors (RLRs). Upon binding to these receptors, poly I:C triggers signaling pathways that lead to the production of type I interferons and other cytokines, which are crucial for antiviral defense.
Toll-like Receptor 3[edit | edit source]
TLR3 is an endosomal receptor that recognizes dsRNA. When poly I:C binds to TLR3, it activates the TRIF-dependent signaling pathway, leading to the activation of NF-κB and IRF3, transcription factors that induce the expression of interferons and pro-inflammatory cytokines.
RIG-I-like Receptors[edit | edit source]
RLRs, including RIG-I and MDA5, are cytoplasmic receptors that detect viral RNA. Poly I:C is primarily recognized by MDA5, which activates the MAVS signaling pathway, resulting in the production of type I interferons.
Applications in Research[edit | edit source]
Poly I:C is extensively used in research to study the immune response to viral infections. It serves as a model for viral dsRNA, allowing researchers to investigate the mechanisms of innate immunity and the role of interferons in antiviral defense. Poly I:C is also used in cancer research to stimulate the immune system and enhance the efficacy of immunotherapy.
Therapeutic Potential[edit | edit source]
Due to its ability to activate the immune system, poly I:C has been explored as a potential therapeutic agent in the treatment of viral infections and cancer. It has been used in clinical trials as an adjuvant to boost the immune response in vaccines and as a direct antiviral agent.
Safety and Side Effects[edit | edit source]
While poly I:C is a powerful immune stimulant, it can also cause significant side effects, including inflammation, fever, and cytokine release syndrome. These effects limit its use in clinical settings, and research is ongoing to develop safer analogs and delivery methods.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD